Hangzhou Biotest Biotech Co Ltd (688767) — Cash Flow Quality Index
Hangzhou Biotest Biotech Co Ltd (688767) has a Cash Flow Quality Index of 2.88x as of September 2025. Operating cash flow of CN¥28.39 Million exceeds net income of CN¥9.86 Million, indicating high earnings quality where cash backs reported profits. Also explore balance sheet size of Hangzhou Biotest Biotech Co Ltd for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hangzhou Biotest Biotech Co Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688767 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year earnings quality comparison for Hangzhou Biotest Biotech Co Ltd. For live market cap and the full company financial profile, see 688767 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.16x | CN¥106.47 Million | CN¥49.25 Million | ▲ +179.8% |
| 2024 | 0.77x | CN¥128.83 Million | CN¥166.78 Million | ▼ -37.3% |
| 2023 | 1.23x | CN¥131.38 Million | CN¥106.61 Million | ▲ +35.6% |
| 2022 | 0.91x | CN¥703.21 Million | CN¥773.58 Million | ▼ -16.3% |
| 2021 | 1.09x | CN¥908.12 Million | CN¥835.76 Million | ▲ +6.0% |
| 2020 | 1.03x | CN¥446.07 Million | CN¥434.97 Million | ▲ +11.6% |
| 2019 | 0.92x | CN¥25.67 Million | CN¥27.94 Million | ▼ -18.2% |
| 2018 | 1.12x | CN¥21.17 Million | CN¥18.85 Million | ▼ -46.7% |
| 2017 | 2.11x | CN¥7.07 Million | CN¥3.36 Million | — |